RxDoctor Payments Data

Bashir Zikria, MD

Sports Medicine · Lutherville, MDNPI 1699741736

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (53.6%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 72.0% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $9,880 and has fallen 52.6% since, to $4,680 in 2025.

$23,897in general payments, 2019–2025

Across 34 payments — averaging $702.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$17K
  • Supreme Orthopedic Systems, LLC$3K
  • Anika Therapeutics, Inc.$2K
  • Arthrosurface Incorporated$2K
  • Vericel Corporation$575
  • Stryker$97
  • plus $24 from 1 others

What the payments were for

  • Consulting fees$2,50010%
  • Speaking & faculty fees$12,80054%
  • Travel & lodging$6,62528%
  • Food & beverage$1,9728%

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,897 in reported general payments places this provider in the 85th percentile of 111 sports medicine providers in Maryland.

See all sports medicine providers in Maryland

Medicare billing

Part B allowed, 2024
$30,916
Medicare patients
90
Services billed
284

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam11$23

Paid to pharmacies, not to this prescriber.

Other sports medicine in Lutherville

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →